Tobacco Smoke and Lung Disease: Who Is Susceptible?
Authors: CURTIS C. HARRIS
Journal: Annals of Internal Medicine (1986)

Editorials1 October 1986Tobacco Smoke and Lung Disease: Who Is Susceptible?CURTIS C. HARRIS, M.D.CURTIS C. HARRIS, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-105-4-607 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptTobacco smoking is considered to be responsible for about 85% of the deaths due to lung cancer and chronic obstructive lung disease and 25% of the deaths due to ischemic heart disease (1). Doll and Peto (2) have calculated that more than 40% of smokers will die prematurely from smoking-related diseases. These results have been obtained primarily from studies of populations. At the level of the individual person, challenging questions remain. Why, for example, does one smoker develop lung cancer; another, ischemic heart disease; a third, both diseases; and a fourth, no or minimal evidence of smoking-related disease? What proportions...References1. Tobacco Smoking. Lyon, France: International Agency for Research on Cancer, World Health Organization; 1986:37-47. (IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, vol. 38). Google Scholar2. DOLLPETO RR. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. JNCI. 1981;66:1191-308. CrossrefMedlineGoogle Scholar3. SKILLRUDOFFORDMILLER DKR. Higher risk of lung cancer in chronic obstructive pulmonary disease: a prospective, matched, controlled study. Ann Intern Med. 1986:105:503-7. LinkGoogle Scholar4. VAN DER WALHUIZINGAORIESLUITERDE VRIES AENHK. Cancer and chronic non-specific lung disease (C.N.S.L.D.). Scand J Respir Dis. 1966;47:161-72. MedlineGoogle Scholar5. RIMINCTON J. Smoking, chronic bronchitis, and lung cancer. Br Med J. 1971;2:373-5. CrossrefMedlineGoogle Scholar6. DAVIS A. Bronchogenic carcinoma in chronic obstructive pulmonary disease. JAMA. 1976;235:621-2. CrossrefGoogle Scholar7. SAMETHUMBLEPATHOK JCD. Personal and family history of respiratory disease and lung cancer risk. Am Rev Respir Dis. 1986. (In press). Google Scholar8. TOKUHATALILIENFELD GA. Familial aggregation of lung cancer in humans. JNCI. 1963;30:289-312. MedlineGoogle Scholar9. TOKUHATALILIENFELD GA. Familial aggregation of lung cancer among hospital patients. Public Health Rep 1963;78:277-83. CrossrefMedlineGoogle Scholar10. COHENGRAVESLEVY BCD. A common familial component in lung cancer and chronic obstructive pulmonary disease. Lancet. 1977;2:523-6. CrossrefMedlineGoogle Scholar11. LYNCH H. Clinical, epidemiologic, and genetic considerations in lung cancer. In: WYATT JP, HARRIS TD, CLARKS MA, eds. Pulmonary Disease: Defense Mechanisms and Populations at Risk. Lexington: 1977. Google Scholar12. OOIELSTONCHENBAILEY-WILSONROTHSCHILD WRVJH. Increased familial risk of lung cancer. JNCI. 1986;76:217-22. MedlineGoogle Scholar13. MULVIHILL J. Host factors in human lung tumors: an example of ecogenetics in oncology. JNCI. 1976;57:3-7. CrossrefMedlineGoogle Scholar14. LYNCHKIMBERLINGMARKVICKA HWS. Genetics and smoking-associated cancers: a study of 485 families. Cancer. 1986; 57:1640-6. CrossrefMedlineGoogle Scholar15. HARRIS C. Role of carcinogens, cocarcinogens and host factors in human cancer risk. In: HARRIS CC, AUTRUP H, eds. Human Carcinogenesis. New York: Academic Press; 1983:941-70. Google Scholar16. . The Health Consequences of Smoking: Cancer: A Report of the Surgeon General. Rockville, Maryland: Department of Health and Human Services; 1982. (publication no. DHHS [PHS] 82-50179). Google Scholar17. IDELLCOHEN SA. Alpha-1-antitrypsin deficiency. Clin Chest Med. 1983;4:359-75. CrossrefMedlineGoogle Scholar18. GADEKFELLSCRYSTAL JGR. Cigarette smoking induces functional antiprotease deficiency in the lower respiratory tract of humans. Science. 1979;206:1315-6. CrossrefMedlineGoogle Scholar19. AFZELIUS B. A human syndrome caused by immotile cilia. Science. 1976;193:317-9. CrossrefMedlineGoogle Scholar20. CAMNERPHILIPSONFRIBERG PKL. Tracheobronchial clearance in twins. Arch Environ Health. 1972;24:82-7. CrossrefMedlineGoogle Scholar21. WILKEYLEEHASSGERRITYYEATESLOURENCO DPFTDR. Mucociliary clearance of deposited particles from the hnman lung: Intra- and inter-subject reproductivity, total and regional lung clearance, and model comparisons. Arch Environ Health. 1980:35:294-303. MedlineGoogle Scholar22. HUBERTFABSITZFEINLEIBGWINN HRMC. Genetic and environmental influences on pulmonary function in adult twins. Am Rev Respir Dis. 1982;125:409-15. MedlineGoogle Scholar23. PETTERSSONCURVALLENZELL BMC. The inhibitory effect of tobacco smoke compound on ciliary activity. Eur J Respir EHs [suppl] 1985;139:89-92. Google Scholar24. MCDOWELLBARRETTHARRISTRUMP ELCB. Abnormal cilia in human bronchial epithelium. Arch Pathol. 1976;100:429-36. Google Scholar25. CRYSTALREYNOLDSKALICA RHA. Bronchoalveoiar lavage: the report of an international conference. Chest. 1986;90:122-31. CrossrefMedlineGoogle Scholar26. RILEYKERR DJ. Oxidant injury of the extracellular matrix: potential role in the pathogenesis of pulmonary emphysema. Lung. 1985: 163:1-13. CrossrefMedlineGoogle Scholar27. HsuHARRISYAMAGUCHITRUMPSCHAFER ICMBP. Induction of ouabain-resistant mutation and sister chromatid exchanges in Chinese hamster cells with chemical carcinogens mediated by human pulmonary macrophages. J Clin Invest. 1979;64:1245-52. CrossrefMedlineGoogle Scholar28. PERERAWEINSTEIN FI. Molecular epidemiology and carcinogen-DNA adduct detection: new approaches to studies of human cancer causation. J Chronic Dis. 1982;35:581-600. CrossrefGoogle Scholar29. HARRISVAHAKANGASAUTRUP CKH. Biochemical and mo lecular epidemiology of human cancer risk. In: SCARPELLI DG, CRAIGHEAD JE, KAUFMAN N, eds. The Pathologist and the Environment. Baltimore: Williams & Wilkins; 1985:101-39. Google Scholar30. GUSELLA J. Recombinant DNA techniques in the diagnosis of inherited disorders. J Clin Invest. 1986;77:1723-6. CrossrefMedlineGoogle Scholar31. NAUBROOKSBATTEY MBJ. L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer. Nature. 1985;318:69-73. CrossrefMedlineGoogle Scholar32. BARBACID M. Oncogenes and human cancer: cause or consequence? Carcinogenesis. 1986;7:1037-42. CrossrefMedlineGoogle Scholar33. HARRIS C. Human tissues and cells in carcinogenesis research. Cancer Res. 1987;47. (In press). MedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: National Cancer Institute, Bethesda, Maryland PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byInvestigation of glutathione S-transferase M1 and T1 deletions in lung cancerChronic bronchitis and chronic obstructive pulmonary disease: Finnish National Guidelines for Prevention and Treatment 1998–2007Human leukocyte glutathione S ‐transferase isozyme (class mu) and susceptibility to smoking‐related cancersAirways inflammation in subjects with chronic bronchitis who have never smoked.Role of Environmental Factors in the Pharmacokinetics of Drugs: Considerations with Respect to Animal Models, P-450 Enzymes, and Probe DrugsExpression of pulmonary cytochrome P4501 A1 and carcinogen DNA adduct formation in high risk subjects for tobacco-related lung cancerEffects of smoking on benzo(α)pyrene- and glutathione-metabolizing enzymes in human lung tissueAnormalidades de la inmunorregulación en el pulmón de fumadoresPossible prognostic value of pulmonaryah-locus-linked enzymes in patients with tobacco-related lung cancerGenetic Diagnosis: Implications for Medical PracticeAssociation of lung cancer and airway particle concentrationLung Cancer: Scalpels, Beams, Drugs, and Probes 1 October 1986Volume 105, Issue 4Page: 607-609KeywordsCardiovascular therapyHeart diseasesLung and intrathoracic tumorsLungsPopulation statistics Issue Published: 1 October 1986 PDF downloadLoading ...